Pharmacogenomics - the future of pharmacy

What are genomics and pharmacogenomics?

Genomics is a study of all of a person's or an organism's genetic material (genes) and how it affects the growth, development and function of the working body.

Pharmacogenomics (or PGx for short) is just one aspect of genomics, and can be defined as the study of how your genetic information influences how you are likely to respond to medicines.

Our Pharmacogenomics Lead, Sophie Harding, has previous experience of using PGx testing within her practice, and in this short video below she explains how PGx will change the role of pharmacists going forward.

If you have any questions, or would like to know more about pharmacogenomics, email Sophie at [email protected]

PGx and you

How could PGx impact my role in healthcare?

The RPS is keen to educate and inform our members on developments within PGx, in order to ensure that pharmacy is prepared to embrace the benefits of PGx for patients across all sectors of healthcare.

Pharmacists could lead on PGx testing across all healthcare sectors, and we're speaking to pharmacists to explore how they expect PGx will affect their practice - watch the videos below to find out more.

Secondary Care and PGx

Specialist Clinical Pharmacist Alex Matos describes how PGx currently impacts his secondary care practice and how he expects it to do so in future.

Community Pharmacy and PGx

Tim Rendell, Head of Pharmacy at Day Lewis pharmacies, explains how he believes pharmacogenomics could impact community pharmacy.

Primary Care and PGx

Jill Swan, Scottish Clinical Leadership Fellow, explains how Pharmacogenomics may impact Primary Care.

Pharmacogenomics podcast

Episode 14 of our RPS Pharma Scene podcast features Sophie talking to English Pharmacy Board member Ciara Duffy about pharmacogenomics. 

They discuss the huge effect PGx is going to have on healthcare - and how pharmacists will be right at the heart of that change.